Overview Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia Status: Completed Trial end date: 2004-01-01 Target enrollment: Participant gender: Summary This purpose of this study is to evaluate the safety and effectiveness of Ramelteon, once daily (QD), in elderly participants with chronic insomnia. Phase: Phase 3 Details Lead Sponsor: Takeda